Upgrade to SI Premium - Free Trial

AnaptysBio (ANAB) PT Lowered to $70 at TD Cowen

August 25, 2026 7:37 AM
TD Cowen analyst Joseph Thome lowered the price target on AnaptysBio (NASDAQ: ANAB) to $70.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change